I agree that this site is using cookies. You can find further informations here.
X
Talamonti, Marina
87  results:
Search for persons X
?
1

Tildrakizumab: the value of a personalized and flexible app..:

Dapavo, Paolo ; Burlando, Martina ; Guarneri, Claudio...
Expert Opinion on Biological Therapy.  24 (2024)  3 - p. 133-138 , 2024
Link: https://doi.org/10.1080/..
 
?
2

Dupilumab for Treatment of Prurigo Nodularis: Real-Life Eff..:

Paganini, Claudia ; Talamonti, Marina ; Maffei, Virginia...
Journal of Clinical Medicine.  13 (2024)  3 - p. 878 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Dupilumab‐associated ocular surface disease or atopic kerat..:

Galluzzo, Marco ; Tofani, Lorenzo ; Spelta, Sara...
Skin Health and Disease.  4 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
4

Long-Term Persistence Rate of Secukinumab in Psoriatic Pati..:

Galluzzo, Marco ; Trovato, Emanuele ; Talamonti, Marina...
Journal of Clinical Medicine.  13 (2024)  13 - p. 3864 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Impact of Upadacitinib on Atopic Keratoconjunctivitis Exace..:

Paganini, Claudia ; Spelta, Sara ; Tofani, Lorenzo...
Journal of Clinical Medicine.  13 (2024)  13 - p. 3818 , 2024
Link: https://doi.org/10.3390/..
 
?
6

Efficacy and Safety of Dupilumab in the Treatment of Hand E..:

Paganini, Claudia ; Maffei, Virginia ; Vellucci, Laura...
Journal of Clinical Medicine.  13 (2024)  7 - p. 1876 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Successful long‐term guselkumab treatment of severe plaque ..:

Galluzzo, Marco ; Marcelli, Lorenzo ; Fico, Angela..
Skin Health and Disease.  4 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
8

Letter in response to the case report: "Recalcitrant genera..:

Paganini, Claudia ; Talamonti, Marina ; Campione, Elena..
JAAD Case Reports.  39 (2023)  - p. 152-154 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Guselkumab for treatment of moderate-to-severe plaque psori..:

Galluzzo, Marco ; Marcelli, Lorenzo ; Vellucci, Laura...
Expert Opinion on Biological Therapy.  23 (2023)  4 - p. 371-381 , 2023
Link: https://doi.org/10.1080/..
 
?
10

Real‐life effectiveness and safety of guselkumab in patient..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  5 - p. 1017-1027 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Efficacy and Safety of Secukinumab in Elderly Patients with..:

Talamonti, Marina ; Russo, Filomena ; Malara, Giovanna...
Clinical, Cosmetic and Investigational Dermatology.  16 (2023)  - p. 847-852 , 2023
Link: https://doi.org/10.2147/..
 
?
12

Secukinumab for the treatment of palmoplantar psoriasis: a ..:

Galluzzo, Marco ; Talamonti, Marina ; Atzori, Laura...
Expert Opinion on Biological Therapy.  22 (2022)  4 - p. 547-554 , 2022
Link: https://doi.org/10.1080/..
 
?
13

Efficacy of Tildrakizumab for the Treatment of Difficult-to..:

Galluzzo, Marco ; Talamonti, Marina ; Cioni, Arnaldo...
Journal of Clinical Medicine.  11 (2022)  9 - p. 2631 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Tildrakizumab in moderate‐to‐severe plaque psoriasis: A mul..:

Caldarola, Giacomo ; Galluzzo, Marco ; Bernardini, Nicoletta...
Dermatologic Therapy.  35 (2022)  6 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
15

Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, ..:

Morelli, Martina ; Galluzzo, Marco ; Scarponi, Claudia...
Vaccines.  10 (2022)  11 - p. 1977 , 2022
Link: https://doi.org/10.3390/..
 
1-15